---
title: "MusclePharm Corporation (MSLPQ.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/MSLPQ.US.md"
symbol: "MSLPQ.US"
name: "MusclePharm Corporation"
industry: "Personal Care Products"
---

# MusclePharm Corporation (MSLPQ.US)

| Item | Detail |
|------|--------|
| Industry | Personal Care Products |

## Company Profile

MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm bran...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-19T04:30:14.000Z

**Overall: C (0.60)**

**Industry**: Personal Care Products

| Metric | Value |
|--------|-------|
| Industry Ranking | 46 / 58 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -18.44% |  |
| Net Profit YoY | -676.85% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 0.00 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 0.00 |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 50.02M |  |


**Multi Score**: C

#### Profit Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 61.75% | A |
| Profit Margin | -38.51% | E |
| Gross Margin | 11.52% | D |

#### Growth Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -18.44% | E |
| Net Profit YoY | -676.85% | E |
| Total Assets YoY | 20.38% | A |
| Net Assets YoY | -56.44% | E |

#### Cash Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -259.71% | D |
| OCF YoY | -18.44% | E |

#### Operating Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 4.56 | A |

#### Debt Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 417.73% | E |


```chart-data:radar
{
  "title": "Longbridge Financial Score - MusclePharm Corporation",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "61.75%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "-38.51%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "11.52%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "E",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-18.44%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "-676.85%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "20.38%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "-56.44%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "E",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-259.71%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "-18.44%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "A",
      "indicators": [
        {
          "name": "Turnover",
          "value": "4.56",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "E",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "417.73%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | Niagen Bioscience (US.NAGE) | A | A | A | B | B | A |
| 02 | L'Oréal S.A. (US.LRLCY) | A | B | B | C | B | B |
| 03 | Beiersdorf (US.BDRFY) | B | C | B | B | B | B |
| 04 | Kao Corporation (US.KAOOY) | B | C | A | C | B | B |
| 05 | ELF Beauty (US.ELF) | B | B | B | C | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/MSLPQ.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/MSLPQ.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/MSLPQ.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.